Global Factor VIII Deficiency Treatment Market 2018 by Manufacturers, Countries, Type and Application, Forecast to 2023

Publisher Name :
Date: 11-Oct-2018
No. of pages: 153

Factor VIII is an essential blood-clotting protein, which is also known as an antihemophilic factor. In individuals, factor VIII is encoded by F8 gene. Defects in F8 gene lead to hemophilia A, a recessive X-linked coagulation disorder. Factor VIII is generated in liver sinusoidal cells and endothelial cells outside the liver across the body. This protein mixes in the bloodstream in an inactive form, and binds to another molecule called von Willebrand factor, until a damage to blood vessels occur. In response to injury, coagulation factor VIII gets activated and separates from von Willebrand factor.

Scope of the Report:

This report studies the Factor VIII Deficiency Treatment market status and outlook of Global and major regions, from angles of players, countries, product types and end industries; this report analyzes the top players in global market, and splits the Factor VIII Deficiency Treatment market by product type and applications/end industries.

The global hemophilia A drugs market segment accounted for the majority market share and will continue to dominate the factor 8 deficiency treatment market for the next few years. Some of the major factors responsible for the market segment's growth is the growing incidence of hemophilia A, the development of novel drugs with extended action, and the increased adoption of prophylactic treatment. Additionally, growing demand for novel recombinant extended half-life products, the emergence of monoclonal antibodies and gene therapy products, and launch of plasma-derived products for recombinant factor VIII at low costs, will also further drive the growth of the factor VIII deficiency treatment market.

The global Factor VIII Deficiency Treatment market is valued at xx million USD in 2017 and is expected to reach xx million USD by the end of 2023, growing at a CAGR of xx% between 2017 and 2023.

The Asia-Pacific will occupy for more market share in following years, especially in China, also fast growing India and Southeast Asia regions.

North America, especially The United States, will still play an important role which cannot be ignored. Any changes from United States might affect the development trend of Factor VIII Deficiency Treatment.

Europe also play important roles in global market, with market size of xx million USD in 2017 and will be xx million USD in 2023, with a CAGR of xx%.

Market Segment by Companies, this report covers

- Pfizer

- Shire

- Bayer HealthCare

- CSL

- Grifols

- Novo Nordisk

- F. Hoffmann-La Roche

- Kedrion

- Octapharma

- Biogen Idec

- BioMarin Pharmaceutical

- Sangamo Therapeutics

- Spark Therapeutics

- Swedish Orphan Biovitrum

- Uniqure NV

- Amarna Therapeutics

- Dimension Therapeutics

Market Segment by Regions, regional analysis covers

North America (United States, Canada and Mexico)

Europe (Germany, France, UK, Russia and Italy)

Asia-Pacific (China, Japan, Korea, India and Southeast Asia)

South America (Brazil, Argentina, Colombia)

Middle East and Africa (Saudi Arabia, UAE, Egypt, Nigeria and South Africa)

Market Segment by Type, covers

- Hemophilia A Drugs

- Hemophilia A Inhibitors Treatment

- Von Willebrand Disease Treatment

Market Segment by Applications, can be divided into

- Hospitals

- Clinics

- Other

Global Factor VIII Deficiency Treatment Market 2018 by Manufacturers, Countries, Type and Application, Forecast to 2023

Table of Contents
1 Factor VIII Deficiency Treatment Market Overview
1.1 Product Overview and Scope of Factor VIII Deficiency Treatment
1.2 Classification of Factor VIII Deficiency Treatment by Types
1.2.1 Global Factor VIII Deficiency Treatment Revenue Comparison by Types (2017-2023)
1.2.2 Global Factor VIII Deficiency Treatment Revenue Market Share by Types in 2017
1.2.3 Hemophilia A Drugs
1.2.4 Hemophilia A Inhibitors Treatment
1.2.5 Von Willebrand Disease Treatment
1.3 Global Factor VIII Deficiency Treatment Market by Application
1.3.1 Global Factor VIII Deficiency Treatment Market Size and Market Share Comparison by Applications (2013-2023)
1.3.2 Hospitals
1.3.3 Clinics
1.3.4 Other
1.4 Global Factor VIII Deficiency Treatment Market by Regions
1.4.1 Global Factor VIII Deficiency Treatment Market Size (Million USD) Comparison by Regions (2013-2023)
1.4.1 North America (USA, Canada and Mexico) Factor VIII Deficiency Treatment Status and Prospect (2013-2023)
1.4.2 Europe (Germany, France, UK, Russia and Italy) Factor VIII Deficiency Treatment Status and Prospect (2013-2023)
1.4.3 Asia-Pacific (China, Japan, Korea, India and Southeast Asia) Factor VIII Deficiency Treatment Status and Prospect (2013-2023)
1.4.4 South America (Brazil, Argentina, Colombia) Factor VIII Deficiency Treatment Status and Prospect (2013-2023)
1.4.5 Middle East and Africa (Saudi Arabia, UAE, Egypt, Nigeria and South Africa) Factor VIII Deficiency Treatment Status and Prospect (2013-2023)
1.5 Global Market Size of Factor VIII Deficiency Treatment (2013-2023)
2 Manufacturers Profiles
2.1 Pfizer
2.1.1 Business Overview
2.1.2 Factor VIII Deficiency Treatment Type and Applications
2.1.2.1 Product A
2.1.2.2 Product B
2.1.3 Pfizer Factor VIII Deficiency Treatment Revenue, Gross Margin and Market Share (2016-2017)
2.2 Shire
2.2.1 Business Overview
2.2.2 Factor VIII Deficiency Treatment Type and Applications
2.2.2.1 Product A
2.2.2.2 Product B
2.2.3 Shire Factor VIII Deficiency Treatment Revenue, Gross Margin and Market Share (2016-2017)
2.3 Bayer HealthCare
2.3.1 Business Overview
2.3.2 Factor VIII Deficiency Treatment Type and Applications
2.3.2.1 Product A
2.3.2.2 Product B
2.3.3 Bayer HealthCare Factor VIII Deficiency Treatment Revenue, Gross Margin and Market Share (2016-2017)
2.4 CSL
2.4.1 Business Overview
2.4.2 Factor VIII Deficiency Treatment Type and Applications
2.4.2.1 Product A
2.4.2.2 Product B
2.4.3 CSL Factor VIII Deficiency Treatment Revenue, Gross Margin and Market Share (2016-2017)
2.5 Grifols
2.5.1 Business Overview
2.5.2 Factor VIII Deficiency Treatment Type and Applications
2.5.2.1 Product A
2.5.2.2 Product B
2.5.3 Grifols Factor VIII Deficiency Treatment Revenue, Gross Margin and Market Share (2016-2017)
2.6 Novo Nordisk
2.6.1 Business Overview
2.6.2 Factor VIII Deficiency Treatment Type and Applications
2.6.2.1 Product A
2.6.2.2 Product B
2.6.3 Novo Nordisk Factor VIII Deficiency Treatment Revenue, Gross Margin and Market Share (2016-2017)
2.7 F. Hoffmann-La Roche
2.7.1 Business Overview
2.7.2 Factor VIII Deficiency Treatment Type and Applications
2.7.2.1 Product A
2.7.2.2 Product B
2.7.3 F. Hoffmann-La Roche Factor VIII Deficiency Treatment Revenue, Gross Margin and Market Share (2016-2017)
2.8 Kedrion
2.8.1 Business Overview
2.8.2 Factor VIII Deficiency Treatment Type and Applications
2.8.2.1 Product A
2.8.2.2 Product B
2.8.3 Kedrion Factor VIII Deficiency Treatment Revenue, Gross Margin and Market Share (2016-2017)
2.9 Octapharma
2.9.1 Business Overview
2.9.2 Factor VIII Deficiency Treatment Type and Applications
2.9.2.1 Product A
2.9.2.2 Product B
2.9.3 Octapharma Factor VIII Deficiency Treatment Revenue, Gross Margin and Market Share (2016-2017)
2.10 Biogen Idec
2.10.1 Business Overview
2.10.2 Factor VIII Deficiency Treatment Type and Applications
2.10.2.1 Product A
2.10.2.2 Product B
2.10.3 Biogen Idec Factor VIII Deficiency Treatment Revenue, Gross Margin and Market Share (2016-2017)
2.11 BioMarin Pharmaceutical
2.11.1 Business Overview
2.11.2 Factor VIII Deficiency Treatment Type and Applications
2.11.2.1 Product A
2.11.2.2 Product B
2.11.3 BioMarin Pharmaceutical Factor VIII Deficiency Treatment Revenue, Gross Margin and Market Share (2016-2017)
2.12 Sangamo Therapeutics
2.12.1 Business Overview
2.12.2 Factor VIII Deficiency Treatment Type and Applications
2.12.2.1 Product A
2.12.2.2 Product B
2.12.3 Sangamo Therapeutics Factor VIII Deficiency Treatment Revenue, Gross Margin and Market Share (2016-2017)
2.13 Spark Therapeutics
2.13.1 Business Overview
2.13.2 Factor VIII Deficiency Treatment Type and Applications
2.13.2.1 Product A
2.13.2.2 Product B
2.13.3 Spark Therapeutics Factor VIII Deficiency Treatment Revenue, Gross Margin and Market Share (2016-2017)
2.14 Swedish Orphan Biovitrum
2.14.1 Business Overview
2.14.2 Factor VIII Deficiency Treatment Type and Applications
2.14.2.1 Product A
2.14.2.2 Product B
2.14.3 Swedish Orphan Biovitrum Factor VIII Deficiency Treatment Revenue, Gross Margin and Market Share (2016-2017)
2.15 Uniqure NV
2.15.1 Business Overview
2.15.2 Factor VIII Deficiency Treatment Type and Applications
2.15.2.1 Product A
2.15.2.2 Product B
2.15.3 Uniqure NV Factor VIII Deficiency Treatment Revenue, Gross Margin and Market Share (2016-2017)
2.16 Amarna Therapeutics
2.16.1 Business Overview
2.16.2 Factor VIII Deficiency Treatment Type and Applications
2.16.2.1 Product A
2.16.2.2 Product B
2.16.3 Amarna Therapeutics Factor VIII Deficiency Treatment Revenue, Gross Margin and Market Share (2016-2017)
2.17 Dimension Therapeutics
2.17.1 Business Overview
2.17.2 Factor VIII Deficiency Treatment Type and Applications
2.17.2.1 Product A
2.17.2.2 Product B
2.17.3 Dimension Therapeutics Factor VIII Deficiency Treatment Revenue, Gross Margin and Market Share (2016-2017)
3 Global Factor VIII Deficiency Treatment Market Competition, by Players
3.1 Global Factor VIII Deficiency Treatment Revenue and Share by Players (2013-2018)
3.2 Market Concentration Rate
3.2.1 Top 5 Factor VIII Deficiency Treatment Players Market Share
3.2.2 Top 10 Factor VIII Deficiency Treatment Players Market Share
3.3 Market Competition Trend
4 Global Factor VIII Deficiency Treatment Market Size by Regions
4.1 Global Factor VIII Deficiency Treatment Revenue and Market Share by Regions
4.2 North America Factor VIII Deficiency Treatment Revenue and Growth Rate (2013-2018)
4.3 Europe Factor VIII Deficiency Treatment Revenue and Growth Rate (2013-2018)
4.4 Asia-Pacific Factor VIII Deficiency Treatment Revenue and Growth Rate (2013-2018)
4.5 South America Factor VIII Deficiency Treatment Revenue and Growth Rate (2013-2018)
4.6 Middle East and Africa Factor VIII Deficiency Treatment Revenue and Growth Rate (2013-2018)
5 North America Factor VIII Deficiency Treatment Revenue by Countries
5.1 North America Factor VIII Deficiency Treatment Revenue by Countries (2013-2018)
5.2 USA Factor VIII Deficiency Treatment Revenue and Growth Rate (2013-2018)
5.3 Canada Factor VIII Deficiency Treatment Revenue and Growth Rate (2013-2018)
5.4 Mexico Factor VIII Deficiency Treatment Revenue and Growth Rate (2013-2018)
6 Europe Factor VIII Deficiency Treatment Revenue by Countries
6.1 Europe Factor VIII Deficiency Treatment Revenue by Countries (2013-2018)
6.2 Germany Factor VIII Deficiency Treatment Revenue and Growth Rate (2013-2018)
6.3 UK Factor VIII Deficiency Treatment Revenue and Growth Rate (2013-2018)
6.4 France Factor VIII Deficiency Treatment Revenue and Growth Rate (2013-2018)
6.5 Russia Factor VIII Deficiency Treatment Revenue and Growth Rate (2013-2018)
6.6 Italy Factor VIII Deficiency Treatment Revenue and Growth Rate (2013-2018)
7 Asia-Pacific Factor VIII Deficiency Treatment Revenue by Countries
7.1 Asia-Pacific Factor VIII Deficiency Treatment Revenue by Countries (2013-2018)
7.2 China Factor VIII Deficiency Treatment Revenue and Growth Rate (2013-2018)
7.3 Japan Factor VIII Deficiency Treatment Revenue and Growth Rate (2013-2018)
7.4 Korea Factor VIII Deficiency Treatment Revenue and Growth Rate (2013-2018)
7.5 India Factor VIII Deficiency Treatment Revenue and Growth Rate (2013-2018)
7.6 Southeast Asia Factor VIII Deficiency Treatment Revenue and Growth Rate (2013-2018)
8 South America Factor VIII Deficiency Treatment Revenue by Countries
8.1 South America Factor VIII Deficiency Treatment Revenue by Countries (2013-2018)
8.2 Brazil Factor VIII Deficiency Treatment Revenue and Growth Rate (2013-2018)
8.3 Argentina Factor VIII Deficiency Treatment Revenue and Growth Rate (2013-2018)
8.4 Colombia Factor VIII Deficiency Treatment Revenue and Growth Rate (2013-2018)
9 Middle East and Africa Revenue Factor VIII Deficiency Treatment by Countries
9.1 Middle East and Africa Factor VIII Deficiency Treatment Revenue by Countries (2013-2018)
9.2 Saudi Arabia Factor VIII Deficiency Treatment Revenue and Growth Rate (2013-2018)
9.3 UAE Factor VIII Deficiency Treatment Revenue and Growth Rate (2013-2018)
9.4 Egypt Factor VIII Deficiency Treatment Revenue and Growth Rate (2013-2018)
9.5 Nigeria Factor VIII Deficiency Treatment Revenue and Growth Rate (2013-2018)
9.6 South Africa Factor VIII Deficiency Treatment Revenue and Growth Rate (2013-2018)
10 Global Factor VIII Deficiency Treatment Market Segment by Type
10.1 Global Factor VIII Deficiency Treatment Revenue and Market Share by Type (2013-2018)
10.2 Global Factor VIII Deficiency Treatment Market Forecast by Type (2018-2023)
10.3 Hemophilia A Drugs Revenue Growth Rate (2013-2023)
10.4 Hemophilia A Inhibitors Treatment Revenue Growth Rate (2013-2023)
10.5 Von Willebrand Disease Treatment Revenue Growth Rate (2013-2023)
11 Global Factor VIII Deficiency Treatment Market Segment by Application
11.1 Global Factor VIII Deficiency Treatment Revenue Market Share by Application (2013-2018)
11.2 Factor VIII Deficiency Treatment Market Forecast by Application (2018-2023)
11.3 Hospitals Revenue Growth (2013-2018)
11.4 Clinics Revenue Growth (2013-2018)
11.5 Other Revenue Growth (2013-2018)
12 Global Factor VIII Deficiency Treatment Market Size Forecast (2018-2023)
12.1 Global Factor VIII Deficiency Treatment Market Size Forecast (2018-2023)
12.2 Global Factor VIII Deficiency Treatment Market Forecast by Regions (2018-2023)
12.3 North America Factor VIII Deficiency Treatment Revenue Market Forecast (2018-2023)
12.4 Europe Factor VIII Deficiency Treatment Revenue Market Forecast (2018-2023)
12.5 Asia-Pacific Factor VIII Deficiency Treatment Revenue Market Forecast (2018-2023)
12.6 South America Factor VIII Deficiency Treatment Revenue Market Forecast (2018-2023)
12.7 Middle East and Africa Factor VIII Deficiency Treatment Revenue Market Forecast (2018-2023)
13 Research Findings and Conclusion
14 Appendix
14.1 Methodology
14.2 Data Source
List of Tables and Figures
Figure Factor VIII Deficiency Treatment Picture
Table Product Specifications of Factor VIII Deficiency Treatment
Table Global Factor VIII Deficiency Treatment and Revenue (Million USD) Market Split by Product Type
Figure Global Factor VIII Deficiency Treatment Revenue Market Share by Types in 2017
Figure Hemophilia A Drugs Picture
Figure Hemophilia A Inhibitors Treatment Picture
Figure Von Willebrand Disease Treatment Picture
Table Global Factor VIII Deficiency Treatment Revenue (Million USD) by Application (2013-2023)
Figure Factor VIII Deficiency Treatment Revenue Market Share by Applications in 2017
Figure Hospitals Picture
Figure Clinics Picture
Figure Other Picture
Table Global Market Factor VIII Deficiency Treatment Revenue (Million USD) Comparison by Regions 2013-2023
Figure North America Factor VIII Deficiency Treatment Revenue (Million USD) and Growth Rate (2013-2023)
Figure Europe Factor VIII Deficiency Treatment Revenue (Million USD) and Growth Rate (2013-2023)
Figure Asia-Pacific Factor VIII Deficiency Treatment Revenue (Million USD) and Growth Rate (2013-2023)
Figure South America Factor VIII Deficiency Treatment Revenue (Million USD) and Growth Rate (2013-2023)
Figure Middle East and Africa Factor VIII Deficiency Treatment Revenue (Million USD) and Growth Rate (2013-2023)
Figure Global Factor VIII Deficiency Treatment Revenue (Million USD) and Growth Rate (2013-2023)
Table Pfizer Basic Information, Manufacturing Base and Competitors
Table Pfizer Factor VIII Deficiency Treatment Type and Applications
Table Pfizer Factor VIII Deficiency Treatment Revenue, Gross Margin and Market Share (2016-2017)
Table Shire Basic Information, Manufacturing Base and Competitors
Table Shire Factor VIII Deficiency Treatment Type and Applications
Table Shire Factor VIII Deficiency Treatment Revenue, Gross Margin and Market Share (2016-2017)
Table Bayer HealthCare Basic Information, Manufacturing Base and Competitors
Table Bayer HealthCare Factor VIII Deficiency Treatment Type and Applications
Table Bayer HealthCare Factor VIII Deficiency Treatment Revenue, Gross Margin and Market Share (2016-2017)
Table CSL Basic Information, Manufacturing Base and Competitors
Table CSL Factor VIII Deficiency Treatment Type and Applications
Table CSL Factor VIII Deficiency Treatment Revenue, Gross Margin and Market Share (2016-2017)
Table Grifols Basic Information, Manufacturing Base and Competitors
Table Grifols Factor VIII Deficiency Treatment Type and Applications
Table Grifols Factor VIII Deficiency Treatment Revenue, Gross Margin and Market Share (2016-2017)
Table Novo Nordisk Basic Information, Manufacturing Base and Competitors
Table Novo Nordisk Factor VIII Deficiency Treatment Type and Applications
Table Novo Nordisk Factor VIII Deficiency Treatment Revenue, Gross Margin and Market Share (2016-2017)
Table F. Hoffmann-La Roche Basic Information, Manufacturing Base and Competitors
Table F. Hoffmann-La Roche Factor VIII Deficiency Treatment Type and Applications
Table F. Hoffmann-La Roche Factor VIII Deficiency Treatment Revenue, Gross Margin and Market Share (2016-2017)
Table Kedrion Basic Information, Manufacturing Base and Competitors
Table Kedrion Factor VIII Deficiency Treatment Type and Applications
Table Kedrion Factor VIII Deficiency Treatment Revenue, Gross Margin and Market Share (2016-2017)
Table Octapharma Basic Information, Manufacturing Base and Competitors
Table Octapharma Factor VIII Deficiency Treatment Type and Applications
Table Octapharma Factor VIII Deficiency Treatment Revenue, Gross Margin and Market Share (2016-2017)
Table Biogen Idec Basic Information, Manufacturing Base and Competitors
Table Biogen Idec Factor VIII Deficiency Treatment Type and Applications
Table Biogen Idec Factor VIII Deficiency Treatment Revenue, Gross Margin and Market Share (2016-2017)
Table BioMarin Pharmaceutical Basic Information, Manufacturing Base and Competitors
Table BioMarin Pharmaceutical Factor VIII Deficiency Treatment Type and Applications
Table BioMarin Pharmaceutical Factor VIII Deficiency Treatment Revenue, Gross Margin and Market Share (2016-2017)
Table Sangamo Therapeutics Basic Information, Manufacturing Base and Competitors
Table Sangamo Therapeutics Factor VIII Deficiency Treatment Type and Applications
Table Sangamo Therapeutics Factor VIII Deficiency Treatment Revenue, Gross Margin and Market Share (2016-2017)
Table Spark Therapeutics Basic Information, Manufacturing Base and Competitors
Table Spark Therapeutics Factor VIII Deficiency Treatment Type and Applications
Table Spark Therapeutics Factor VIII Deficiency Treatment Revenue, Gross Margin and Market Share (2016-2017)
Table Swedish Orphan Biovitrum Basic Information, Manufacturing Base and Competitors
Table Swedish Orphan Biovitrum Factor VIII Deficiency Treatment Type and Applications
Table Swedish Orphan Biovitrum Factor VIII Deficiency Treatment Revenue, Gross Margin and Market Share (2016-2017)
Table Uniqure NV Basic Information, Manufacturing Base and Competitors
Table Uniqure NV Factor VIII Deficiency Treatment Type and Applications
Table Uniqure NV Factor VIII Deficiency Treatment Revenue, Gross Margin and Market Share (2016-2017)
Table Amarna Therapeutics Basic Information, Manufacturing Base and Competitors
Table Amarna Therapeutics Factor VIII Deficiency Treatment Type and Applications
Table Amarna Therapeutics Factor VIII Deficiency Treatment Revenue, Gross Margin and Market Share (2016-2017)
Table Dimension Therapeutics Basic Information, Manufacturing Base and Competitors
Table Dimension Therapeutics Factor VIII Deficiency Treatment Type and Applications
Table Dimension Therapeutics Factor VIII Deficiency Treatment Revenue, Gross Margin and Market Share (2016-2017)
Table Global Factor VIII Deficiency Treatment Revenue (Million USD) by Players (2013-2018)
Table Global Factor VIII Deficiency Treatment Revenue Share by Players (2013-2018)
Figure Global Factor VIII Deficiency Treatment Revenue Share by Players in 2016
Figure Global Factor VIII Deficiency Treatment Revenue Share by Players in 2017
Figure Global Top 5 Players Factor VIII Deficiency Treatment Revenue Market Share in 2017
Figure Global Top 10 Players Factor VIII Deficiency Treatment Revenue Market Share in 2017
Figure Global Factor VIII Deficiency Treatment Revenue (Million USD) and Growth Rate (%) (2013-2018)
Table Global Factor VIII Deficiency Treatment Revenue (Million USD) by Regions (2013-2018)
Table Global Factor VIII Deficiency Treatment Revenue Market Share by Regions (2013-2018)
Figure Global Factor VIII Deficiency Treatment Revenue Market Share by Regions (2013-2018)
Figure Global Factor VIII Deficiency Treatment Revenue Market Share by Regions in 2017
Figure North America Factor VIII Deficiency Treatment Revenue and Growth Rate (2013-2018)
Figure Europe Factor VIII Deficiency Treatment Revenue and Growth Rate (2013-2018)
Figure Asia-Pacific Factor VIII Deficiency Treatment Revenue and Growth Rate (2013-2018)
Figure South America Factor VIII Deficiency Treatment Revenue and Growth Rate (2013-2018)
Figure Middle East and Africa Factor VIII Deficiency Treatment Revenue and Growth Rate (2013-2018)
Table North America Factor VIII Deficiency Treatment Revenue by Countries (2013-2018)
Table North America Factor VIII Deficiency Treatment Revenue Market Share by Countries (2013-2018)
Figure North America Factor VIII Deficiency Treatment Revenue Market Share by Countries (2013-2018)
Figure North America Factor VIII Deficiency Treatment Revenue Market Share by Countries in 2017
Figure USA Factor VIII Deficiency Treatment Revenue and Growth Rate (2013-2018)
Figure Canada Factor VIII Deficiency Treatment Revenue and Growth Rate (2013-2018)
Figure Mexico Factor VIII Deficiency Treatment Revenue and Growth Rate (2013-2018)
Table Europe Factor VIII Deficiency Treatment Revenue (Million USD) by Countries (2013-2018)
Figure Europe Factor VIII Deficiency Treatment Revenue Market Share by Countries (2013-2018)
Figure Europe Factor VIII Deficiency Treatment Revenue Market Share by Countries in 2017
Figure Germany Factor VIII Deficiency Treatment Revenue and Growth Rate (2013-2018)
Figure UK Factor VIII Deficiency Treatment Revenue and Growth Rate (2013-2018)
Figure France Factor VIII Deficiency Treatment Revenue and Growth Rate (2013-2018)
Figure Russia Factor VIII Deficiency Treatment Revenue and Growth Rate (2013-2018)
Figure Italy Factor VIII Deficiency Treatment Revenue and Growth Rate (2013-2018)
Table Asia-Pacific Factor VIII Deficiency Treatment Revenue (Million USD) by Countries (2013-2018)
Figure Asia-Pacific Factor VIII Deficiency Treatment Revenue Market Share by Countries (2013-2018)
Figure Asia-Pacific Factor VIII Deficiency Treatment Revenue Market Share by Countries in 2017
Figure China Factor VIII Deficiency Treatment Revenue and Growth Rate (2013-2018)
Figure Japan Factor VIII Deficiency Treatment Revenue and Growth Rate (2013-2018)
Figure Korea Factor VIII Deficiency Treatment Revenue and Growth Rate (2013-2018)
Figure India Factor VIII Deficiency Treatment Revenue and Growth Rate (2013-2018)
Figure Southeast Asia Factor VIII Deficiency Treatment Revenue and Growth Rate (2013-2018)
Table South America Factor VIII Deficiency Treatment Revenue by Countries (2013-2018)
Table South America Factor VIII Deficiency Treatment Revenue Market Share by Countries (2013-2018)
Figure South America Factor VIII Deficiency Treatment Revenue Market Share by Countries (2013-2018)
Figure South America Factor VIII Deficiency Treatment Revenue Market Share by Countries in 2017
Figure Brazil Factor VIII Deficiency Treatment Revenue and Growth Rate (2013-2018)
Figure Argentina Factor VIII Deficiency Treatment Revenue and Growth Rate (2013-2018)
Figure Colombia Factor VIII Deficiency Treatment Revenue and Growth Rate (2013-2018)
Table Middle East and Africa Factor VIII Deficiency Treatment Revenue (Million USD) by Countries (2013-2018)
Table Middle East and Africa Factor VIII Deficiency Treatment Revenue Market Share by Countries (2013-2018)
Figure Middle East and Africa Factor VIII Deficiency Treatment Revenue Market Share by Countries (2013-2018)
Figure Middle East and Africa Factor VIII Deficiency Treatment Revenue Market Share by Countries in 2017
Figure Saudi Arabia Factor VIII Deficiency Treatment Revenue and Growth Rate (2013-2018)
Figure UAE Factor VIII Deficiency Treatment Revenue and Growth Rate (2013-2018)
Figure Egypt Factor VIII Deficiency Treatment Revenue and Growth Rate (2013-2018)
Figure Nigeria Factor VIII Deficiency Treatment Revenue and Growth Rate (2013-2018)
Figure South Africa Factor VIII Deficiency Treatment Revenue and Growth Rate (2013-2018)
Table Global Factor VIII Deficiency Treatment Revenue (Million USD) by Type (2013-2018)
Table Global Factor VIII Deficiency Treatment Revenue Share by Type (2013-2018)
Figure Global Factor VIII Deficiency Treatment Revenue Share by Type (2013-2018)
Figure Global Factor VIII Deficiency Treatment Revenue Share by Type in 2017
Table Global Factor VIII Deficiency Treatment Revenue Forecast by Type (2018-2023)
Figure Global Factor VIII Deficiency Treatment Market Share Forecast by Type (2018-2023)
Figure Global Hemophilia A Drugs Revenue Growth Rate (2013-2018)
Figure Global Hemophilia A Inhibitors Treatment Revenue Growth Rate (2013-2018)
Figure Global Von Willebrand Disease Treatment Revenue Growth Rate (2013-2018)
Table Global Factor VIII Deficiency Treatment Revenue by Application (2013-2018)
Table Global Factor VIII Deficiency Treatment Revenue Share by Application (2013-2018)
Figure Global Factor VIII Deficiency Treatment Revenue Share by Application (2013-2018)
Figure Global Factor VIII Deficiency Treatment Revenue Share by Application in 2017
Table Global Factor VIII Deficiency Treatment Revenue Forecast by Application (2018-2023)
Figure Global Factor VIII Deficiency Treatment Market Share Forecast by Application (2018-2023)
Figure Global Hospitals Revenue Growth Rate (2013-2018)
Figure Global Clinics Revenue Growth Rate (2013-2018)
Figure Global Other Revenue Growth Rate (2013-2018)
Figure Global Factor VIII Deficiency Treatment Revenue (Million USD) and Growth Rate Forecast (2018 -2023)
Table Global Factor VIII Deficiency Treatment Revenue (Million USD) Forecast by Regions (2018-2023)
Figure Global Factor VIII Deficiency Treatment Revenue Market Share Forecast by Regions (2018-2023)
Figure North America Factor VIII Deficiency Treatment Revenue Market Forecast (2018-2023)
Figure Europe Factor VIII Deficiency Treatment Revenue Market Forecast (2018-2023)
Figure Asia-Pacific Factor VIII Deficiency Treatment Revenue Market Forecast (2018-2023)
Figure South America Factor VIII Deficiency Treatment Revenue Market Forecast (2018-2023)
Figure Middle East and Africa Factor VIII Deficiency Treatment Revenue Market Forecast (2018-2023)
  • Global Low Molecular Weight Heparin Market Insights, Forecast to 2025
    Published: 15-Mar-2019        Price: US 3900 Onwards        Pages: 110
    Low Molecular Weight Heparin (LMWHs) is derived from UFH (Unfractionated heparin) by such processes as chemical degradation, enzymatic depolymerisation and gamma-radiation cleavage. Natural heparin consists of molecular chains of varying lengths, or molecular weights. Chains of varying molecular weights, from 5000 to over 40,000 Daltons, make up polydisperse pharmaceutical-grade heparin. LMWHs, in contrast, consist of only short chains of polysaccharide. LMWHs are defined as heparin salts ......
  • Global Intravenous Immunoglobulin (IVIg) Market Insights, Forecast to 2025
    Published: 15-Mar-2019        Price: US 3900 Onwards        Pages: 114
    Intravenous Immunoglobulin, also called gamma globulin or antibodies, is a highly purified blood product preparation that is derived from large pools of plasma donors. Plasma from approximately 1,000 to 10,000 persons is present in each unit or "lot" of Intravenous Immunoglobulin. North America region is the largest supplier of intravenous immunoglobulin (IVIg), with a production market share nearly 48% in 2016. Europe is the second largest supplier of intravenous immunoglobulin (IVIg), e......
  • Global Heparin Sodium Market Insights, Forecast to 2025
    Published: 11-Mar-2019        Price: US 3900 Onwards        Pages: 117
    Heparin sodium is an anticoagulant (blood thinner) that prevents the formation of blood clots. Heparin is used to treat and prevent blood clots in the veins, arteries, or lung. It is also used before surgery to reduce the risk of blood clots. The global Heparin Sodium market is valued at xx million US$ in 2018 and will reach xx million US$ by the end of 2025, growing at a CAGR of xx% during 2019-2025. The objectives of this study are to define, segment, and project the size of the Heparin......
  • Global Hemophilia Drugs Market Research Report 2019
    Published: 11-Mar-2019        Price: US 2900 Onwards        Pages: 107
    The hemophilia treatment drugs market is experiencing entry of a large number of new drugs in the market. Few of them have already arrived and other long lasting clotting factors and more promising drugs are on their way to get launched in this market. For instance, follow up data from phase I/II study of hemophilia medicine ‘Emicizumab' by Roche has demonstrated promising results regarding safety and prophylactic efficiency in people with severe hemophilia A. Another example is of ‘Eloctate' fo......
  • Global Antithrombotic Drugs Market Research Report 2019
    Published: 11-Mar-2019        Price: US 2900 Onwards        Pages: 98
    Thrombosis is may be defined as the formation of blood clot in the blood vessel or lumen part of the blood vessel. Formation of blood clots inside the blood vessel causes disruption of blood flow and it leads to cause death of cells. Deep vein thrombosis (DVT) is one type of thrombosis and it affects larger muscle of thigh. As a result, it causes pain, swelling in the leg and also it causes pulmonary embolism. Deep vein thrombosis (DVT) and pulmonary embolism collectively called as venous thromb......
  • Global Fibrinogen Concentrate Industry Market Research Report
    Published: 07-Mar-2019        Price: US 2960 Onwards        Pages: 114
    The Fibrinogen Concentrate market revenue was xx.xx Million USD in 2014, grew to xx.xx Million USD in 2018, and will reach xx.xx Million USD in 2024, with a CAGR of x.x% during 2019-2024. Based on the Fibrinogen Concentrate industrial chain, this report mainly elaborates the definition, types, applications and major players of Fibrinogen Concentrate market in details. Deep analysis about market status (2014-2019), enterprise competition pattern, advantages and disadvantages of enterprise Product......
  • Global Anticoagulants Market Insights, Forecast to 2025
    Published: 06-Mar-2019        Price: US 3900 Onwards        Pages: 110
    Anticoagulants, commonly referred to as blood thinners, are substances that prevent or reduce coagulation of blood, prolonging the clotting time. Some of them occur naturally in blood-eating animals such as leeches and mosquitoes, where they help keep the bite area unclotted long enough for the animal to obtain some blood. As a class of medications, anticoagulants are used in therapy for thrombotic disorders. Oral anticoagulants (OACs) are taken by many people in pill or tablet form, and various......
  • Global Injectable Anticoagulants Market Insights, Forecast to 2025
    Published: 06-Mar-2019        Price: US 3900 Onwards        Pages: 118
    The injectable anticoagulants include low molecular weight heparin (LMWH) agents (dalteparin [Fragmin®], enoxaparin [Lovenox®]) and factor Xa inhibitors (fondaparinux [Arixtra®]). In the last several years, global market of injectable anticoagulants developed slowly. In 2016, global revenue of injectable anticoagulants is nearly 5300 M USD. And the global growth rate is slow. The classification of injectable anticoagulants includes LMWH, DTI and other, and the proportion of LMWH in......
  • Global Hemophilia Drugs Market Status and Future Forecast 2015-2024
    Published: 06-Mar-2019        Price: US 4500 Onwards        Pages: 151
    Summary The report forecast global Hemophilia Drugs market to grow to reach xxx Million USD in 2019 with a CAGR of xx% during the period 2020-2024. The report offers detailed coverage of Hemophilia Drugs industry and main market trends. The market research includes historical and forecast market data, demand, application details, price trends, and company shares of the leading Hemophilia Drugs by geography. The report splits the market size, by volume and value, on ......
  • SERVICES
    Value for Money
    We believe in "optimum utilization of available budget and resources". While servicing our clients' (your) market research requirements, we keep the same approach in focus to help you get the best value for your $$s.
    Ever Growing Inventory
    Ranging from the smallest feasible / required data (datasheets, data facts, SWOT analysis, company profiles, etc) to full research reports that help you make decisions, our inventory is updated almost on a daily basis with the latest industry reports from domain experts that track more than 5000 niche sectors.
    One Stop Solution
    Need a custom research report on medical devices market? Require all available business intelligence on 3D printing industry? Exploring F&B sector of a particular country/region? RnRMarketResearch.com is your one-stop-solution to all market intelligence needs. We not only offer custom research and consulting services, we also "bundle" reports to meet your needs and help you fetch the data analysis you require for your business.
    Dedicated Client Engagement
    Not limited to only "finding" relevant reports for you, our client engagement team dedicates its efforts to understand your "business need" and accordingly maps available research data to help you move forward. Call "your" client engagement executive any time of your day and get your questions answered in order to make the correct business decision.
    Saving Time and Efforts
    Simply share your research requirement details with us and let us do all the hard work to find required intelligence for you. When you add up our "one stop solution" and "dedicated client engagement" services mentioned above, you obviously know the time and effort saving you do by working with us.
    Payment Flexibility
    Working with Fortune 500 organizations, we understand the importance of being flexible for payments. Share your payment terms with us and we will surely match up to them to ensure you get access to required business intelligence data without having to wait for the payment to be done.
    Post-Purchase Research Support
    Have questions after reading a report / datasheet bought through us? Not sure about the methodology used for data available in the research? Talk to us / Share your questions with us and if required, we will connect you with the analyst(s)/author(s) of the report(s) and ensure you get satisfactory answers for the same. Need more data / analysis / report(s) on the topic of your research/project? The RnRMarketResearch.com team is here for you 24X7 to support you with your post-purchase requirements. Subscription Offers & Packages (Get in touch with us for more details - sales@rnrmarketresearch.com / +1 888 391 5441 )
    • Ad Hoc
    • Pay - as - you - go / Bucket Subscriptions
    • Fixed Cost for #of reports
    • Customize / Personalize as per your needs